• 1
    Gubler, D. J., Dengue and dengue hemorrhagic fever. Clin. Microbiol. Rev. 1998. 11: 480496.
  • 2
    da Fonseca, B. A. and Fonseca, S. N., Dengue virus infections. Curr. Opin. Pediatr. 2002. 14: 6771.
  • 3
    Morens, D. M. and Fauci, A. S., Dengue and hemorrhagic fever: a potential threat to public health in the United States. J. Am. Med. Assoc. 2008. 299: 214216.
  • 4
    Guzman, M. G. and Kouri, G., Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J. Clin. Virol. 2003. 27: 113.
  • 5
    Green, S. and Rothman, A., Immunopathological mechanisms in dengue and dengue hemorrhagic fever. Curr. Opin. Infect. Dis. 2006. 19: 429436.
  • 6
    Monath, T. P., Dengue and yellow fever – challenges for the development and use of vaccines. N. Engl. J. Med. 2007. 357: 22222225.
  • 7
    Rothman, A. L., Immunology and immunopathogenesis of dengue disease. Adv. Virus Res. 2003. 60: 397419.
  • 8
    Moran, E., Simmons, C., Vinh Chau, N., Luhn, K., Wills, B., Dung, N. P., Thao le, T. T. et al., Preservation of a critical epitope core region is associated with the high degree of flaviviral cross-reactivity exhibited by a dengue-specific CD4+ T cell clone. Eur. J. Immunol. 2008. 38: 10501057.
  • 9
    Phipps, R. P., Stein, S. H. and Roper, R. L., A new view of prostaglandin E regulation of the immune response. Immunol. Today 1991. 12: 349352.
  • 10
    Steer, S. A. and Corbett, J. A., The role and regulation of COX-2 during viral infection. Viral Immunol. 2003. 16: 447460.
  • 11
    Wahl, L. M., Corcoran, M. L., Pyle, S. W., Arthur, L. O., Harel-Bellan, A. and Farrar, W. L., Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidonic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 1989. 86: 621625.
  • 12
    Janelle, M. E., Gravel, A., Gosselin, J., Tremblay, M. J. and Flamand, L., Activation of monocyte cyclooxygenase-2 gene expression by human herpesvirus 6. Role for cyclic AMP-responsive element-binding protein and activator protein-1. J. Biol. Chem. 2002. 277: 3066530674.
  • 13
    Savard, M., Belanger, C., Tremblay, M. J., Dumais, N., Flamand, L., Borgeat, P. and Gosselin, J., EBV suppresses prostaglandin E2 biosynthesis in human monocytes. J. Immunol. 2000. 164: 64676473.
  • 14
    Wu, S. J., Grouard-Vogel, G., Sun, W., Mascola, J. R., Brachtel, E., Putvatana, R., Louder, M. K. et al., Human skin Langerhans cells are targets of dengue virus infection. Nat. Med. 2000. 6: 816820.
  • 15
    Ho, L. J., Wang, J. J., Shaio, M. F., Kao, C. L., Chang, D. M., Han, S. W. and Lai, J. H., Infection of human dendritic cells by dengue virus causes cell maturation and cytokine production. J. Immunol. 2001. 166: 14991506.
  • 16
    Tassaneetrithep, B., Burgess, T. H., Granelli-Piperno, A., Trumpfheller, C., Finke, J., Sun, W., Eller, M. A.,, DC-SIGN (CD209) mediates dengue virus infection of human dendritic cells. J. Exp. Med. 2003. 197: 823829.
  • 17
    Luplertlop, N., Misse, D., Bray, D., Deleuze, V., Gonzalez, J. P., Leardkamolkarn, V., Yssel, H. and Veas, F., Dengue-virus-infected dendritic cells trigger vascular leakage through metalloproteinase overproduction. EMBO Rep. 2006. 7: 11761181.
  • 18
    Ho, L. J., Shaio, M. F., Chang, D. M., Liao, C. L. and Lai, J. H., Infection of human dendritic cells by dengue virus activates and primes T cells towards Th0-like phenotype producing both Th1 and Th2 cytokines. Immunol. Invest. 2004. 33: 423437.
  • 19
    Ho, L. J., Hung, L. F., Weng, C. Y., Wu, W. L., Chou, P., Lin, Y. L., Chang, D. M. et al., Dengue virus type 2 antagonizes IFN-alpha but not IFN-gamma antiviral effect via down-regulating Tyk2-STAT signaling in the human dendritic cell. J. Immunol. 2005. 174: 81638172.
  • 20
    Steer, S. A., Moran, J. M., Maggi, L. B., Jr., Buller, R. M., Perlman, H. and Corbett, J. A., Regulation of cyclooxygenase-2 expression by macrophages in response to double-stranded RNA and viral infection. J. Immunol. 2003. 170: 10701076.
  • 21
    Palmer, D. R., Sun, P., Celluzzi, C., Bisbing, J., Pang, S., Sun, W., Marovich, M. A. and Burgess, T., Differential effects of dengue virus on infected and bystander dendritic cells. J. Virol. 2005. 79: 24322439.
  • 22
    Liou, J. T., Chen, Z. Y., Ho, L. J., Yang, S. P., Chang, D. M., Liang, C. C. and Lai, J. H., Differential effects of triptolide and tetrandrine on activation of COX-2, NF-kappaB, and AP-1 and virus production in dengue virus-infected human lung cells. Eur. J. Pharmacol. 2008. 589: 288298.
  • 23
    Ruocco, M. G., Maeda, S., Park, J. M., Lawrence, T., Hsu, L. C., Cao, Y., Schett, G. et al., IkappaB kinase (IKK)beta, but not IKKalpha, is a critical mediator of osteoclast survival and is required for inflammation-induced bone loss. J. Exp. Med. 2005. 201: 16771687.
  • 24
    Johnson, R. A., Ma, X. L., Yurochko, A. D. and Huang, E. S., The role of MKK1/2 kinase activity in human cytomegalovirus infection. J. Gen. Virol. 2001. 82: 493497.
  • 25
    Johnson, R. A., Huong, S. M. and Huang, E. S., Inhibitory effect of 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)1H - imidazole on HCMV DNA replication and permissive infection. Antiviral Res. 1999. 41: 101111.
  • 26
    Mizutani, T., Fukushi, S., Ishii, K., Sasaki, Y., Kenri, T., Saijo, M., Kanaji, Y. et al., Mechanisms of establishment of persistent SARS-CoV-infected cells. Biochem. Biophys. Res. Commun. 2006. 347: 261265.
  • 27
    Hassan, M., Ghozlan, H. and Abdel-Kader, O., Activation of c-Jun NH2-terminal kinase (JNK) signaling pathway is essential for the stimulation of hepatitis C virus (HCV) non-structural protein 3 (NS3)-mediated cell growth. Virology 2005. 333: 324336.
  • 28
    Zapata, H. J., Nakatsugawa, M. and Moffat, J. F., Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J. Virol. 2007. 81: 977990.
  • 29
    Caposio, P., Musso, T., Luganini, A., Inoue, H., Gariglio, M., Landolfo, S. and Gribaudo, G., Targeting the NF-kappaB pathway through pharmacological inhibition of IKK2 prevents human cytomegalovirus replication and virus-induced inflammatory response in infected endothelial cells. Antiviral Res. 2007. 73: 175184.
  • 30
    Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767811.
  • 31
    Martin, P., Ruiz, S. R., del Hoyo, G. M., Anjuere, F., Vargas, H. H., Lopez-Bravo, M. and Ardavin, C., Dramatic increase in lymph node dendritic cell number during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood 2002. 99: 12821288.
  • 32
    MartIn-Fontecha, A., Sebastiani, S., Hopken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A. and Sallusto, F., Regulation of dendritic cell migration to the draining lymph node: impact on T lymphocyte traffic and priming. J. Exp. Med. 2003. 198: 615621.
  • 33
    Ohl, L., Mohaupt, M., Czeloth, N., Hintzen, G., Kiafard, Z., Zwirner, J., Blankenstein, T. et al., CCR7 governs skin dendritic cell migration under inflammatory and steady-state conditions. Immunity 2004. 21: 279288.
  • 34
    Humrich, J. Y., Thumann, P., Greiner, S., Humrich, J. H., Averbeck, M., Schwank, C., Kampgen, E. et al., Vaccinia virus impairs directional migration and chemokine receptor switch of human dendritic cells. Eur. J. Immunol. 2007. 37: 954965.
  • 35
    Scandella, E., Men, Y., Gillessen, S., Forster, R. and Groettrup, M., Prostaglandin E2 is a key factor for CCR7 surface expression and migration of monocyte-derived dendritic cells. Blood 2002. 100: 13541361.
  • 36
    Legler, D. F., Krause, P., Scandella, E., Singer, E. and Groettrup, M., Prostaglandin E2 is generally required for human dendritic cell migration and exerts its effect via EP2 and EP4 receptors. J. Immunol. 2006. 176: 966973.
  • 37
    Libraty, D. H., Pichyangkul, S., Ajariyakhajorn, C., Endy, T. P. and Ennis, F. A., Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis. J. Virol. 2001. 75: 35013508.
  • 38
    Ho, L. J., Juan, T. Y., Chao, P., Wu, W. L., Chang, D. M., Chang, S. Y. and Lai, J. H., Plant alkaloid tetrandrine downregulates IkappaBalpha kinases-IkappaBalpha-NF-kappaB signaling pathway in human peripheral blood T cell. Br. J. Pharmacol. 2004. 143: 919927.
  • 39
    Scandella, E., Men, Y., Legler, D. F., Gillessen, S., Prikler, L., Ludewig, B. and Groettrup, M., CCL19/CCL21-triggered signal transduction and migration of dendritic cells requires prostaglandin E2. Blood 2004. 103: 15951601.